This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Industry-Academic Cooperation Foundation Gyeongsang National University, Stemcentric Co., Ltd.. Active years: 2025.
Company Filing History:
1 out of 102 
1 out of 1 Years Active: 2025
Title: Innovations of Si Jung Jang in Male Infertility Treatment
Introduction
Si Jung Jang is an innovative inventor based in Jinji si, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of male infertility. His work focuses on utilizing pluripotent stem cells derived from periodontal tissue to develop effective pharmaceutical compositions.
Latest Patents
Si Jung Jang holds a patent for a pharmaceutical composition comprising periodontal tissue-derived pluripotent stem cells for the prevention or treatment of male infertility. This invention relates to a composition that includes vitrified periodontal tissue-derived mesenchymal stem cells. The composition aims to recover sex hormone levels in the seminiferous tubules of atrophic testes and blood to normal levels. This is achieved through the improvement of lipid metabolism enzyme activity in the liver, demonstrating remarkable prophylactic and therapeutic effects on male infertility. The mesenchymal stem cells used in this invention can be obtained in a non-invasive manner, making them a promising option for cell therapy products targeting male infertility.
Career Highlights
Throughout his career, Si Jung Jang has been associated with notable institutions, including the Industry-Academic Cooperation Foundation at Gyeongsang National University and Stemcentric Co., Ltd. His work in these organizations has contributed to advancements in medical research and applications.
Collaborations
Si Jung Jang has collaborated with esteemed colleagues such as Gyu Jin Rho and Kyung Min Kim. Their joint efforts have furthered research in the field of stem cell therapy and its applications in treating male infertility.
Conclusion
Si Jung Jang's innovative work in developing pharmaceutical compositions for male infertility treatment showcases the potential of using periodontal tissue-derived stem cells. His contributions to medical science are paving the way for new therapeutic options in this critical area of health.